Porphyria, Acute Intermittent: Clinical Trials

1 trial for Porphyria, Acute Intermittent, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Porphyria, Acute Intermittent: new trials by email Literature Review of Porphyria, Acute Intermittent trials Research Report on Porphyria, Acute Intermittent

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panhematin for Prevention of Acute Attacks of Porphyria
Hemin for injection, Placebo - Acute Intermittent Porphyria, Hereditary Coproporphyria
Phase 2TerminatedThe University of Texas Medical Branch, Galveston132015-10-302026-01-30

Narrower conditions

Coproporphyria, Hereditary (1)  ·  Porphyria, Variegate (1)  ·  Porphyrias (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Porphyrias, Hepatic (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Hemin (1)  ·  Injections (1)

Sponsors

The University of Texas Medical Branch, Galveston (1)

Countries

United States (1)

Top investigators

Karl E Anderson, MD (1)